Position of omalizumab therapy in the treatment of spontaneous chronic urticaria. A case series and literature review
Aleksander Obtułowicz et al · Termedia Publishing House · 2022
Accesso alla risorsa
Apri il contenuto dall’opzione principale o scegli un’altra fonte disponibile.
Accesso aperto disponibile
Come citare
Elegí el formato que necesitás y copiá la referencia al portapapeles.
APA 7
al, A. O. E. (2022). Position of omalizumab therapy in the treatment of spontaneous chronic urticaria. A case series and literature review. https://doi.org/10.5114/dr.2022.116736
MLA
al, Aleksander Obtułowicz et. "Position of omalizumab therapy in the treatment of spontaneous chronic urticaria. A case series and literature review." 2022. https://doi.org/10.5114/dr.2022.116736.
Chicago
al, Aleksander Obtułowicz et. 2022. "Position of omalizumab therapy in the treatment of spontaneous chronic urticaria. A case series and literature review.". https://doi.org/10.5114/dr.2022.116736.
Harvard
al, A. O. E. 2022, Position of omalizumab therapy in the treatment of spontaneous chronic urticaria. A case series and literature review, Termedia Publishing House, available at: https://doi.org/10.5114/dr.2022.116736 [Accessed 5 Aug. 2026].
Dettagli della risorsa
Informazioni bibliografiche utili per verificare che sia il materiale corretto.
- Titolo
- Position of omalizumab therapy in the treatment of spontaneous chronic urticaria. A case series and literature review
- Autore / collaboratori
- Aleksander Obtułowicz et al
- Editore
- Termedia Publishing House
- Anno di pubblicazione
- 2022
- ISSN
- 0033-2526
- ISSN
- 0033-2526
- Lingua
- Inglés
Soggetti
Esplora risorse correlate a partire da questi soggetti.